Case-crossover analysis of condom use and herpes simplex virus type 2 acquisition

Sexually Transmitted Diseases

Volumn 39, Issue 5, 2012, Pages 388-393

  Stanaway, Jeffrey D ^a   Wald, Anna ^a,b   Martin, Emily T ^c   Gottlieb, Sami L ^d   Magaret, Amalia S ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANALYTICAL RESEARCH; ARTICLE; CONDOM; CONTROLLED STUDY; FEMALE; FOLLOW UP; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; RISK REDUCTION; SELF REPORT; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; CONDOMS; CROSS-OVER STUDIES; FEMALE; FOLLOW-UP STUDIES; HERPES GENITALIS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEXUAL BEHAVIOR; YOUNG ADULT;

EID: 84859896935     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e318248aa8a     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. Condoms and STDs: Fact sheet for public health personnel. April 11, 2011. Available at: http://www.cdc.gov/ condomeffectiveness/latex.htm. Accessed June 25, 2011.
2. Casper C, Wald A. Condom use and the prevention of genital herpes acquisition. Herpes 2002; 9:10-14. (Pubitemid 37489856)
3. Langenberg A. Interrupting herpes simplex virus type 2 transmission: The role of condoms and microbicides. Herpes 2004; 11(suppl 3):147A-154A.
4. Bryson Y, Dillon M, Bernstein DI, et al. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: A prospective couple study. J Infect Dis 1993; 167:942-946. (Pubitemid 23088267)
5. Mertz GJ, Benedetti J, Ashley R, et al. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116:197-202.
6. Austin H, Macaluso M, Nahmias A, et al. Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic. Sex Transm Dis 1999; 26:329-334. (Pubitemid 29296351)
7. Butler T, Donovan B, Taylor J, et al. Herpes simplex virus type 2 in prisoners, New South Wales, Australia. Int J STD AIDS 2000; 11:743-747.
8. Huerta K, Berkelhamer S, Klein J, et al. Epidemiology of herpes simplex virus type 2 infections in a high-risk adolescent population. J Adolesc Health 1996; 18:384-386. (Pubitemid 26192813)
9. Wald A, Koutsky L, Ashley RL, et al. Genital herpes in a primary care clinic. Demographic and sexual correlates of herpes simplex type 2 infections. Sex Transm Dis 1997; 24:149-155. (Pubitemid 27123190)
10. Gottlieb SL, Douglas JM Jr, Foster M, et al. Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis 2004; 190:1059-1067. (Pubitemid 39186791)
11. Martin ET, Krantz E, Gottlieb SL, et al. A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Arch Intern Med 2009; 169:1233-1240.
12. Wald A, Langenberg AG, Krantz E, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 2005; 143:707-713.
13. Wald A, Langenberg AG, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001; 285:3100-3106. (Pubitemid 32578207)
14. Gallo MF, Warner L, Macaluso M, et al. Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic. Sex Transm Dis 2008; 35: 679-685.
15. Peterman TA, Lin LS, Newman DR, et al. Does measured behavior reflect STD risk? An analysis of data from a randomized controlled behavioral intervention study. Project RESPECT Study Group. Sex Transm Dis 2000; 27:446-451. (Pubitemid 30666946)
16. Greenland S. A unified approach to the analysis of case-distribution (case only) studies. Stat Med 1999; 18:1-15. (Pubitemid 29015328)
17. Maclure M, Mittleman MA. Should we use a case-crossover design? Annu Rev Public Health 2000; 21:193-221. (Pubitemid 30480322)
18. Mittleman MA, Maclure M, Robins JM. Control sampling strategies for case-crossover studies: An assessment of relative efficiency. Am J Epidemiol 1995; 142:91-98.
19. Warner L, Macaluso M, Austin HD, et al. Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness. Am J Epidemiol 2005; 161:765-773.
20. Corey L, Langenberg AG, Ashley R, et al. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: Two randomized controlled trials. JAMA 1999; 282: 331-340. (Pubitemid 29350487)
21. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350:11-20. (Pubitemid 38032179)
22. Kamb ML, Fishbein M, Douglas JM Jr, et al. Efficacy of riskreduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: A randomized controlled trial. Project RESPECT Study Group. JAMA 1998; 280:1161-1167. (Pubitemid 28457806)
23. Noell J, Rohde P, Ochs L, et al. Incidence and prevalence of chlamydia, herpes, and viral hepatitis in a homeless adolescent population. Sex Transm Dis 2001; 28:4-10. (Pubitemid 32064202)
24. Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347:1652-1661. (Pubitemid 35340783)
25. Ashley RL, Eagleton M, Pfeiffer N. Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection. J Clin Microbiol 1999; 37: 1632-1633. (Pubitemid 29187857)
26. Ashley-Morrow R, Krantz E, Wald A. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex Transm Dis 2003; 30:310-314. (Pubitemid 36397831)
27. Wald A, Krantz E, Selke S, et al. Knowledge of partners' genital herpes protects against herpes simplex virus type 2 acquisition. J Infect Dis 2006; 194:42-52.
28. Fishbein M, Pequegnat W. Evaluating AIDS prevention interventions using behavioral and biological outcome measures. Sex Transm Dis 2000; 27:101-110. (Pubitemid 30082880)
29. Pinkerton SD, Chesson HW, Layde PM. Utility of behavioral changes as markers of sexually transmitted disease risk reduction in sexually transmitted disease/HIV prevention trials. J Acquir Immun Defic Syndr 2002; 31:71-79.
30. Rose E, Diclemente RJ, Wingood GM, et al. The validity of teens' and young adults' self-reported condom use. Arch Pediatr Adolesc Med 2009; 163:61-64.